Investment in American manufacturing is on the rise, with pharmaceutical giant Merck recently announcing a landmark $1 billion investment to establish a manufacturing plant in Wilmington, Delaware.

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as ...

With the backing of a new special taxing district in De Soto, Oddo Development hopes to break ground on a mixed-housing ...

The reach of the med-tech patent wars now includes devices for electroencephalography thanks to a complaint recently filed by Sunnyvale, Calif.-based Ceribell Inc. with the U.S. International Trade ...

Kennedy is vowing to "fix" the federal program for compensating Americans injured by vaccines, opening the door to sweeping ...

Germany’s Merck KGaA (MRK: DE) has reported second quarter earnings that missed analyst expectations. The life sciences company’s earnings before interest, taxes, depreciation and amortization (EBITDA ...

NEW YORK (Reuters) -Woes for U.S. healthcare stocks have worsened this year driven partly by Trump administration policies, ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor ...

AI cloud firm CoreWeave is buying an entire tech and life science campus where it previously leased a single data center.

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...